Tanaka M - Search Results

1

Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency.

Komaki H, Nishigaki Y, Fuku N, Hosoya H, Murayama K, Ohtake A, Goto Y, Wakamoto H, Koga Y, Tanaka M. Komaki H, et al. Among authors: tanaka m. Biochim Biophys Acta. 2010 Mar;1800(3):313-5. doi: 10.1016/j.bbagen.2009.07.008. Epub 2009 Jul 17. Biochim Biophys Acta. 2010. PMID: 19616603

2

Pyruvate therapy for mitochondrial DNA depletion syndrome.

Saito K, Kimura N, Oda N, Shimomura H, Kumada T, Miyajima T, Murayama K, Tanaka M, Fujii T. Saito K, et al. Among authors: tanaka m. Biochim Biophys Acta. 2012 May;1820(5):632-6. doi: 10.1016/j.bbagen.2011.08.006. Epub 2011 Aug 11. Biochim Biophys Acta. 2012. PMID: 21855607

3

[Mitochondrial genome and longevity].

Nishigaki Y, Tanaka M. Nishigaki Y, et al. Among authors: tanaka m. Nihon Rinsho. 2009 Jul;67(7):1299-305. Nihon Rinsho. 2009. PMID: 19591276 Review. Japanese.

4

Efficacy of pyruvate therapy in patients with mitochondrial disease: a semi-quantitative clinical evaluation study.

Fujii T, Nozaki F, Saito K, Hayashi A, Nishigaki Y, Murayama K, Tanaka M, Koga Y, Hiejima I, Kumada T. Fujii T, et al. Among authors: tanaka m. Mol Genet Metab. 2014 Jun;112(2):133-8. doi: 10.1016/j.ymgme.2014.04.008. Epub 2014 May 2. Mol Genet Metab. 2014. PMID: 24830361

5

Mitochondrial haplogroups associated with lifestyle-related diseases and longevity in the Japanese population.

Nishigaki Y, Fuku N, Tanaka M. Nishigaki Y, et al. Among authors: tanaka m. Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S221-35. doi: 10.1111/j.1447-0594.2010.00599.x. Geriatr Gerontol Int. 2010. PMID: 20590837 Review.

6

Beneficial effect of pyruvate therapy on Leigh syndrome due to a novel mutation in PDH E1α gene.

Koga Y, Povalko N, Katayama K, Kakimoto N, Matsuishi T, Naito E, Tanaka M. Koga Y, et al. Among authors: tanaka m. Brain Dev. 2012 Feb;34(2):87-91. doi: 10.1016/j.braindev.2011.03.003. Epub 2011 Mar 31. Brain Dev. 2012. PMID: 21454027

7

Extended screening for major mitochondrial DNA point mutations in patients with hereditary hearing loss.

Kato T, Nishigaki Y, Noguchi Y, Fuku N, Ito T, Mikami E, Kitamura K, Tanaka M. Kato T, et al. Among authors: tanaka m. J Hum Genet. 2012 Dec;57(12):772-5. doi: 10.1038/jhg.2012.109. Epub 2012 Sep 13. J Hum Genet. 2012. PMID: 22971729

8

Mitochondrial research in Asia: A step for the mito-global conference.

Koga Y Prof, Wei YH Director and Chairman, Prof, Tanaka M Prof. Koga Y Prof, et al. Among authors: tanaka m prof. Biochim Biophys Acta Gen Subj. 2020 Sep;1864(9):129638. doi: 10.1016/j.bbagen.2020.129638. Epub 2020 May 29. Biochim Biophys Acta Gen Subj. 2020. PMID: 32473926 No abstract available.

9

Metabolic analysis of 13C-labeled pyruvate for noninvasive assessment of mitochondrial function.

Wu IC, Ohsawa I, Fuku N, Tanaka M. Wu IC, et al. Among authors: tanaka m. Ann N Y Acad Sci. 2010 Jul;1201:111-20. doi: 10.1111/j.1749-6632.2010.05636.x. Ann N Y Acad Sci. 2010. PMID: 20649547 Review.

10

GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases.

Fujita Y, Ito M, Kojima T, Yatsuga S, Koga Y, Tanaka M. Fujita Y, et al. Among authors: tanaka m. Mitochondrion. 2015 Jan;20:34-42. doi: 10.1016/j.mito.2014.10.006. Epub 2014 Nov 1. Mitochondrion. 2015. PMID: 25446397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,421 results

Search Page

Filters